NVS vs. EQNR
Compare and contrast key facts about Novartis AG (NVS) and Equinor ASA (EQNR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NVS or EQNR.
Performance
NVS vs. EQNR - Performance Comparison
Returns By Period
In the year-to-date period, NVS achieves a 5.66% return, which is significantly higher than EQNR's -17.48% return.
NVS
5.66%
-12.31%
-0.08%
12.41%
8.08%
6.67%
EQNR
-17.48%
-0.79%
-13.79%
-19.44%
11.44%
N/A
Fundamentals
| NVS | EQNR | |
|---|---|---|
| Market Cap | $209.76B | $62.38B |
| EPS | $5.73 | $3.27 |
| PE Ratio | 18.31 | 6.89 |
| PEG Ratio | 3.12 | 3.57 |
| Total Revenue (TTM) | $49.29B | $104.81B |
| Gross Profit (TTM) | $36.69B | $35.07B |
| EBITDA (TTM) | $19.83B | $41.19B |
Key characteristics
| NVS | EQNR | |
|---|---|---|
| Sharpe Ratio | 0.81 | -0.74 |
| Sortino Ratio | 1.17 | -0.90 |
| Omega Ratio | 1.16 | 0.89 |
| Calmar Ratio | 0.90 | -0.58 |
| Martin Ratio | 2.59 | -1.41 |
| Ulcer Index | 5.19% | 14.15% |
| Daily Std Dev | 16.57% | 26.81% |
| Max Drawdown | -41.72% | -66.92% |
| Current Drawdown | -15.00% | -29.87% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between NVS and EQNR is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
NVS vs. EQNR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and Equinor ASA (EQNR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NVS vs. EQNR - Dividend Comparison
NVS's dividend yield for the trailing twelve months is around 3.68%, less than EQNR's 9.60% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVS Novartis AG | 3.68% | 3.44% | 3.91% | 4.08% | 3.40% | 2.87% | 3.72% | 3.50% | 4.06% | 3.51% | 3.14% | 3.37% |
EQNR Equinor ASA | 9.60% | 9.80% | 4.13% | 2.24% | 4.32% | 4.85% | 2.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
NVS vs. EQNR - Drawdown Comparison
The maximum NVS drawdown since its inception was -41.72%, smaller than the maximum EQNR drawdown of -66.92%. Use the drawdown chart below to compare losses from any high point for NVS and EQNR. For additional features, visit the drawdowns tool.
Volatility
NVS vs. EQNR - Volatility Comparison
The current volatility for Novartis AG (NVS) is 5.85%, while Equinor ASA (EQNR) has a volatility of 10.41%. This indicates that NVS experiences smaller price fluctuations and is considered to be less risky than EQNR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NVS vs. EQNR - Financials Comparison
This section allows you to compare key financial metrics between Novartis AG and Equinor ASA. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities